PAXLOVID

Date

March 2022

Description

Paxlovid (ritonavir-boosted nirmatrelvir) are oral antiviral pills used for the treatment of mild to moderate COVID-19 disease. This box was prescribed under a US Food and Drug Administration (FDA) emergency use authorization (EUA) in March 2022.

Source

US Department of Health and Human Services (HHS), Centers for Disease Control and Prevention (CDC), Pfizer BioNTech